The 2nd International Conference on Precision Medicine and AI Healthcare (HealthAI2027) will be held on July 12–13, 2027 in the vibrant city of Hamburg, Germany. Organized by PAGES, this global gathering will unite clinicians, researchers, healthcare leaders, AI innovators, and policymakers to explore the transformative role of artificial intelligence and personalized medicine in improving patient outcomes.
HealthAI2027 offers a unique platform to showcase breakthrough research to an international audience of healthcare professionals, AI innovators, and policy leaders. Attendees will explore cutting-edge advancements in genomics, AI-powered diagnostics, digital health, and medical data science. Beyond presentations, the conference fosters meaningful global partnerships that bridge the gap between medicine, technology, and healthcare policy—driving real-world impact and shaping the future of precision medicine.
HealthAI2027 provides a dynamic platform for presenting breakthrough research, discussing cutting-edge technologies, and fostering collaborations between medicine, data science, and healthcare innovation. With keynote lectures, interactive sessions, workshops, and networking opportunities, this conference is a must-attend event for anyone shaping the future of healthcare.
Join us in Hamburg for HealthAI2027 and be part of the global movement redefining the future of healthcare through precision, innovation, and intelligence.
May 30th, 2027
August 21st, 2026
November 21st, 2026
July 12-13, 2027
Neu-Ulm University of Applied Sciences (HNU)
Germany
Neu-Ulm University of Applied Sciences (HNU)
Germany
Prof. Dr. Patrick Da-Cruz is Professor of Business Administration and Healthcare Management at Neu-Ulm University of Applied Sciences (HNU), Germany, and Academic Director of its MBA programme in Healthcare Management. With extensive experience in healthcare strategy, pharmaceutical and healthcare industries, and management consulting, he focuses on healthcare management, leadership, innovation, and digital transformation. He is also an experienced speaker, author, mentor, and advisory board member.
The Johns Hopkins University School of Medicine
USA
The Johns Hopkins University School of Medicine
USA
Dr. Robert H. Getzenberg, Ph.D. is an accomplished oncology and precision medicine expert with extensive experience in urology, cancer research, biomarkers, molecular diagnostics, and clinical development. He has held senior academic and industry positions, including at Johns Hopkins University School of Medicine and Astellas Pharma. His expertise spans prostate cancer, biomarker-driven medicine, translational oncology, clinical trials, and innovative cancer therapeutics, with a strong focus on advancing personalized approaches to cancer diagnosis and treatment.
Join as a conference speaker and present your work to a global audience.
Register NowShowcase your research with a poster presentation and engage with attendees.
Register NowDiscounted rate for students and trainees with a valid institutional ID.
Register NowHamburg, Germany's second-largest city, is a vibrant destination renowned for its rich maritime heritage, world-class infrastructure, and dynamic blend of history and modernity. Located on the banks of the River Elbe, the city is celebrated for its iconic harbor, stunning architecture, picturesque canals, and green spaces, making it one of Europe's most attractive and livable urban centers.
The city offers an exceptional cultural experience with renowned landmarks such as the Elbphilharmonie, the historic Speicherstadt, lively waterfront districts, museums, galleries, and diverse culinary traditions. With its welcoming atmosphere, excellent public transportation, and international outlook, Hamburg provides visitors with an unforgettable experience that combines innovation, culture, and timeless charm.
An outstanding conference with an impeccable lineup of speakers. The insights I gained were invaluable for my research. Truly a must-attend event in the field.
The networking opportunities were phenomenal. I connected with several potential collaborators. The organization was seamless from start to finish.
As a PhD student, the poster sessions and direct access to leading scientists were incredibly inspiring. I left with new ideas and a renewed passion for my work.
